Bio-Connect
ICC/IF analysis of 293T cells transfected with Htt23Q and Htt148Q stop constructs ending in amino acid 586 using GTX54522 Huntingtin (neoepitope 586) antibody. Fixation : Formalin Permeabilization : 0.1% Triton X-100 in TBS for 10 minutes Dilution : 1:50 for at least 1 hour at room temperature
ICC/IF analysis of 293T cells transfected with Htt23Q and Htt148Q stop constructs ending in amino acid 586 using GTX54522 Huntingtin (neoepitope 586) antibody. Fixation : Formalin Permeabilization : 0.1% Triton X-100 in TBS for 10 minutes Dilution : 1:50 for at least 1 hour at room temperature
ICC/IF analysis of 293T cells transfected with Htt23Q and Htt148Q stop constructs ending in amino acid 586 using GTX54522 Huntingtin (neoepitope 586) antibody. Fixation : Formalin Permeabilization : 0.1% Triton X-100 in TBS for 10 minutes Dilution : 1:50 for at least 1 hour at room temperature

Huntingtin (neoepitope 586) antibody

Research Use Only
GTX54522
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
Product group Antibodies
ReactivityHuman, Mouse
TargetHTT
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Huntingtin (neoepitope 586) antibody
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody recognizes the 586 cleaved fragment without detecting the full-length form.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.6 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID3064
  • Target name
    HTT
  • Target description
    huntingtin
  • Target synonyms
    HD; huntingtin; huntington disease protein; IT15; LOMARS
  • Host
    Rabbit
  • Isotype
    IgG
  • Scientific Description
    Huntingtin is a disease gene linked to Huntingtons disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntingtons disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5 UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
  • Reactivity
    Human, Mouse
  • Storage Instruction
    2°C to 8°C,-20°C or -80°C
  • UNSPSC
    12352203